P38 MAPK inhibitor, cbs3830 limits vascular remodelling in arterialised vein grafts

Heart Lung and Circulation

Volumn 22, Issue 9, 2013, Pages 751-758

  Ge, Jian Jun ^a   Zhao, Zhi Wei ^a   Zhou, Zheng Chun ^a   Wu, Song ^a   Zhang, Rui ^a   Pan, Fa ming ^a   Abendroth, Dietmar Karl ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Adventitia hyperplasia; Arterio venous bypass; Intimal hypeplasia; Medial hyperplasia; P38 MAPK inhibitor; Vein graft

Indexed keywords

CBS 3830; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; UNCLASSIFIED DRUG;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY INTERPOSITION GRAFT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYPERPLASIA; JUGULAR VEIN; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; VEIN DISEASE; VEIN GRAFT;

ADVENTITIA HYPERPLASIA; ARTERIALIZED VEIN GRAFTS; ARTERIO-VENOUS BYPASS; AVGS; CHD; CON; CONTROL; CORONARY HEART DISEASE; EC; ENDOTHELIAL CELLS; ERK; EXTRACELLULAR-SIGNAL REGULATED KINAS; IH; INTIMAL HYPEPLASIA; INTIMAL HYPERPLASIA; MAPKS; MEDIAL HYPERPLASIA; MITOGEN ACTIVATED PROTEIN KINASES; NEOINTIMAL HYPERPLASIA; NIH; P38 MAPK; P38 MAPK-INHIBITOR; P38 MITOGEN ACTIVATED PROTEIN KINASES; PATTERN RECOGNITION RECEPTORS; PCNA; PDGF-BB; PLATELET DERIVED GROWTH FACTOR BB; PROLIFERATING CELL NUCLEAR ANTIGEN; PRRS; SHAM; SHAM-OPERATED; SMC; SMOOTH MUSCLE CELLS; VEIN GRAFT;

ADVENTITIA; ANIMALS; CORONARY ARTERY BYPASS; GENE EXPRESSION REGULATION; GRAFT OCCLUSION, VASCULAR; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SAPHENOUS VEIN; TUNICA INTIMA;

EID: 84884354677     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.02.006     Document Type: Article

References (38)

1. Zhang X.H., Lu Z.L., Liu L. Coronary heart disease in China. Heart 2008, 94(9):1126-1131.
2. Shah P.J., Gordon I., Fuller J., Seevanayagam S., Rosalion A., Tatoulis J., et al. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg 2003, 126:1972-1977.
3. Goldman S., Zadina K., Moritz T., Ovitt T., Sethi G., Copeland J.G., et al. VA Cooperative Study Group #207/297/364, Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004, 44:2149-2156.
4. Arima M., Kanoh T., Suzuki T., Kuremoto K., Tanimoto K., Oigawa T., et al. Serial angiographic follow-up beyond 10 years after coronary artery bypass grafting. Circ J 2005, 69:896-902.
5. Motwani J.G., Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998, 97:916-931.
6. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999, 79:143-180.
7. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37.
8. Lai K., Wang H., Lee W.S., Jain M.K., Lee M.E., Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest 1996, 98:1560.
9. Lille S., Daum G., Clowes M.M., Clowes A.W. The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery. J Surg Res 1997, 70:178.
10. Hu Y., Cheng L., Hochleitner B.W., Xu Q. Activation of mitogenactivated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 1997, 17:2808.
11. Saunders P.C., Pintucci G., Bizekis C.S., Sharony R., Hyman K.M., Saponara F., et al. Vein graft arterialization causes differential activation of mitogen-activated protein kinases. J Thorac Cardiovasc Surg 2004, 127:1276.
12. Gulkarov I., Bohmann K., Cinnante K.M., Pirelli L., Yu P.J., Grau J.B., et al. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts. J Surg Res 2009, 154(1):150-156.
13. Pintucci G., Saunders P.C., Gulkarov I., Sharony R., Kadian-Dodov D.L., Bohmann K., et al. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. FASEB J 2006, 20:398.
14. Koeberle S.C., Romir J., Fischer S., Koeberle A., Schattel V., Albrecht W., et al. Skepinone-l is a selective p38 mitogen-activated protein kinase inhibitor. Nat Chem Biol 2011, 8:141-143.
15. Zou Y., Dietrich H., Hu Y., Metzler B., Wick G., Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998, 153(4):1301-1310.
16. Pyle A.L., Li B., Maupin A.B., Guzman R.J., Crimmins D.L., Olson S., et al. Biomechanical stress induces novel arterial intima-enriched genes: implications for vascular adaptation to stress. Cardiovascular Pathology 2010, 19(2):e13-e20.
17. Mayr M., Li C., Zou Y., Huemer U., Hu Y., Xu Q. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000, 15:261-270.
18. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1014-R1030.
19. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
20. Zou Y., Hu Y., Metzler B., Xu Q. Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells. Int J Mol Med 1998, 1(5):827-834.
21. Land W. Innate alloimmunity: history and current knowledge. Exp Clin Transplant 2007, 5:575-584.
22. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
23. Dardik A., Yamashita A., Aziz F., Asada H., Sumpio B.E. Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. J Vasc Surg 2005, 41(2):321-331.
24. Dardik A., Yamashita A., Aziz F., Asada H., Sumpio B.E. Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha. Am J Physiol Heart Circ Physiol 2004, 286:H1845-H1852.
25. Zampetaki A., Zhang Z., Hu Y., Xu Q. Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NFκB signaling pathways. Am J Physiol Heart Circ Physiol 2005, 288:H2946-H2954.
26. Schachner T. Pharmacologic inhibition of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg 2006, 131:1065-1072.
27. Cornelissen J., Armstrong J., Holt C.M. Mechanical stretch induces phosphorylation of p38-MAPK and apoptosis in human saphenous vein. Arterioscler Thromb Vasc Biol 2004, 24:451-456.
28. Ehsan A., Mann M.J., Dell'Acqua G., Tamura K., Braun-Dullaeus R., Dzau V.J. Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease. Circulation 2002, 105:1686-1692.
29. Xu Q., Zhang Z., Davison F., Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003, 93(8):E76-E86.
30. Monroe D.M., Hoffman M., Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002, 22:1381-1389.
31. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986, 314(8):488-500.
32. Bush H.L., Jakubowski J.A., Curl G.R., Deykin D., Nabseth D.C. The natural history of endothelial structure and function in arterialized vein grafts. J Vasc Surg 1986, 3:204-215.
33. Shi Y., O'Brien J.E., Mannion J.D., Morrison R.C., Chung W., Fard A., et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997, 95:2684-2693.
34. Cano E., Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 1995, 20:117-122.
35. Shi Y., O'Brien J.E., Fard A., Mannion J.D., Wang D., Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
36. Miller F.J. Adventitial fibroblasts: backstage journeymen. Arterioscler Thromb Vasc Biol 2001, 21:722-723.
37. Li G., Chen S.J., Oparil S., Chen Y.F., Thompson J.A. Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 2000, 101:1362-1365.
38. Scott N.A., Cipolla G.D., Ross C.E., Dunn B., Martin F.H., Simonet L., et al. Identification of potential role for the adventitia in vascular lesion formation after balloon overstrench injury of porcine coronary arteries. Circulation 1996, 93(2):2178-2187.